Badar T et al. |
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies. |
2015 |
Clin Lymphoma Myeloma Leuk |
pmid:25795639
|
Zhang W et al. |
Vaginal Microbicide Film Combinations of Two Reverse Transcriptase Inhibitors, EFdA and CSIC, for the Prevention of HIV-1 Sexual Transmission. |
2015 |
Pharm. Res. |
pmid:25794967
|
Leonhardt I et al. |
The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity. |
2015 |
MBio |
pmid:25784697
|
Horev B et al. |
pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. |
2015 |
ACS Nano |
pmid:25661192
|
De Loof A |
The essence of female-male physiological dimorphism: differential Ca2+-homeostasis enabled by the interplay between farnesol-like endogenous sesquiterpenoids and sex-steroids? The Calcigender paradigm. |
2015 |
Gen. Comp. Endocrinol. |
pmid:25540913
|
Léger T et al. |
The metacaspase (Mca1p) has a dual role in farnesol-induced apoptosis in Candida albicans. |
2015 |
Mol. Cell Proteomics |
pmid:25348831
|
Katragkou A et al. |
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. |
2015 |
J. Antimicrob. Chemother. |
pmid:25288679
|
Bandara HM et al. |
Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro. |
2016 |
Mol. Pharm. |
pmid:27383205
|
Inoue Y et al. |
Farnesol-Induced Disruption of the Staphylococcus aureus Cytoplasmic Membrane. |
2016 |
Biol. Pharm. Bull. |
pmid:27150138
|
Léger T et al. |
The Metacaspase (Mca1p) Restricts O-glycosylation During Farnesol-induced Apoptosis in Candida albicans. |
2016 |
Mol. Cell Proteomics |
pmid:27125826
|